The nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor is a non-opioid branch of the opioid receptor family implicated in several neurological and psychological disorders, such as pain, anxiety, depression, involuntary movement, addiction, seizure and dementia. Heterogeneity of NOP receptors has been proposed based on the findings of splicing variants and from binding and functional studies. We have previously reported that Ro 64-6198, a NOP receptor agonist, activated a subset, but not all, of N/OFQ-sensitive NOP receptors in midbrain ventrolateral periaqueductal grey (vlPAG). In this study, we found that a new NOP receptor ligand, (+)-5a Compound ((3aS, 6aR)-1-(cis-4-isopropylcyclohexyl)-5k-methyl-2k-phenylhexahydrospiro [piperidine-4,1k-pyrrolo[3, 4-c]pyrrole]), also activated a subset of NOP receptors in vlPAG neurons. (+)-5a Compound (0.1-30 mM) concentration-dependently activated G-protein-coupled inwardly-rectifying potassium (GIRK) channels mediated through the NOP receptors in about 35 % of the recorded vlPAG neurons. (+)-5a Compound (EC 50 : 605 nM) was less potent (1/12) and efficacious (47 %) than N/OFQ. In (+)-5a Compound-insensitive neurons, Ro 64-6198 was also ineffective, and vice versa, but N/OFQ activated GIRK channels through NOP receptors. In (+)-5a Compoundsensitive neurons, (+)-5a Compound precluded the effect of Ro 64-6198. Immunofluorecent and morphometric studies showed that most of the (+)-5a Compound-sensitive neurons were multipolar with intensive dendritic arborization and immunoreactive to glutamic acid decarboxylase-67. It is suggested that (+)-5a Compound activates a subset of NOP receptors, similar to the Ro 64-6198-sensitive subset, in the vlPAG neurons which are mostly GABAergic. These results further support the presence of functional heterogeneity of NOP receptors in the midbrain PAG.
Introduction
An orphan G-protein-coupled receptor (GPCR) was cloned and named initially as ORL1 (opioid receptor-like receptor), because, although having a structure highly homologous to classical opioid receptors, it displayed little affinity for opioids (Mollereau et al. 1994) . This receptor was deorphanized through identifying its endogenous ligand, a heptadecapeptide named nociceptin (Meunier et al. 1995) or orphanin FQ (Reinscheid et al. 1995) , and renamed as nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor. It is classified as a non-opioid branch of the opioid receptor family (NC-IUPHAR, 2004) . N/OFQ and NOP receptors are widely distributed in the brain and involved in many neuropsychological functions or disorders, including pain, anxiety, depression, addiction, feeding, learning and memory, motor control and central cardiovascular regulation Lambert, 2008) . N/OFQ also regulates neurotransmitter release in the autonomic nervous system and plays a role peripherally in the pathogenesis of asthma, urine retention or cardiovascular function Lambert, 2008) . Among these, the anxiolytic effect of N/OFQ (Jenck et al. 1997) or Ro 64-6198 , a non-peptide NOP receptor agonist, is noteworthy. Recently, several newly developed non-peptide NOP receptor agonists also showed anxiolytic effect in various animal models (Hirao et al. 2008 ; Varty et al. 2008) . Unlike benzodiazepines, the NOP receptor agonist did not affect ethanol-induced hypnosis (Hirao et al. 2008) . Recently, Ro 64-6198 was shown to have analgesic effects in monkeys at very low systemic doses similar to a reference opioid, alfentanil, but without any of the side-effects of opioids, such as respiratory depression or abuse liability (Ko et al. 2009) . Given these potential clinical applications, it is important to characterize the pharmacological profiles of non-peptide NOP receptor ligands and to understand their mode of action.
Ro 64-6198 is the first non-peptide NOP receptor agonist with good brain permeability and has been used in several studies to reveal the functional roles and nature of NOP receptors (Ko et al. 2009 ; Shoblock, 2007) . Interestingly, Ro 64-6198, although having similar binding affinity and efficacy as N/OFQ at cloned NOP receptors, mimicked some, but not all, of the effects of N/OFQ in several functional studies Goeldner et al. 2008 ; Reiss et al. 2008 ; Shoblock, 2007) . Moreover, the NOP receptor transcript was found to have splicing variants although no coding product was reported (Peluso et al. 1998) . Mathis et al. (1999 Mathis et al. ( , 1997 , also reported that there are two (high and low) specific binding sites of N/OFQ in the rodent brain. These findings suggest the possibility of NOP receptor heterogeneity.
We have previously found that Ro 64-6198 activated only a subset of the N/OFQ-sensitive NOP receptors in ventrolateral periaqueductal grey (vlPAG) neurons in isolated rat midbrain slices . (+)-5a Compound ((3aS,6aR)-1-(cis-4-isopropylcyclohexyl)-5k-methyl-2k-phenylhexahydrospiro [piperidine-4,1k-pyrrolo[3,4-c] pyrrole]) is a non-peptide ligand of NOP receptors with a structure backbone analogous to Ro 64-6198 (Kolczewski et al. 2003) . It acts as a full agonist of NOP receptors and is 1.7-and 25-fold less potent than N/OFQ in expressed hNOP receptor-mediated GTPcS binding and cAMP reduction, respectively (Kolczewski et al. 2003) . Importantly, (+)-5a Compound is more selective for NOP receptors over other opioid receptors than Ro 64-6198, with overall >1000-fold binding selectivity (Kolczewski et al. 2003) .
In this study, using the same midbrain slice preparations, we have quantitatively characterized the pharmacological profile of (+)-5a Compound at native NOP receptors of vlPAG neurons, and compared its effect with N/OFQ and Ro 64-6198. The midbrain PAG was chosen because it is one of the brain regions with dense distribution of NOP receptors (Anton et al. 1996 ; Neal et al. 1999) . Activation of NOP receptors has been reported to result in activation of G protein-coupled inwardly rectifying K + (GIRK) channels, inhibition of Ca 2+ channels and reduction of cAMP (Henderson & McKnight, 1997 ; Mogil & Pasternak, 2001 ). Through NOP receptor-mediated GIRK channel activation, N/OFQ can reduce neuronal excitability via membrane hyperpolarization in several brain regions, including PAG (Liao et al. 2009 ; Vaughan et al. 1997) . We, therefore, used the magnitude of GIRK current as a functional assay for NOP receptor activity in vlPAG neurons. The effect of (+)-5a Compound and its interactions with N/OFQ and Ro 64-6198 were examined and compared in Ro 64-6198-sensitive and -insensitive neurons.
Methods

Brain slice preparations
All animal experimental procedures were approved by the Institutional Animal Care and Use Committee of the College of Medicine, National Taiwan University. All efforts were made to minimize the number of animals used. The dissection of PAG slices, electrophysiological recordings and data analyses were similar to our previous study (Liao et al. 2009) .
The midbrain blocks containing PAG were rapidly dissected from Wistar rats (postnatal days 9-18). Coronal slices (400 mm) were then sectioned with a vibrotome (Microslicer DTK-100, Japan) and equilibrated at room temperature in artificial cerebral spinal fluid (aCSF). The aCSF consisted of (mM) : 117 NaCl, 4.5 KCl, 2.5 CaCl 2 , 1.2 MgCl 2 , 1.2 NaH 2 PO 4 , 25 NaHCO 3 and 11.4 dextrose (pH 7.4), and was oxygenated with 95 % O 2 /5 % CO 2 . After equilibration for at least 1 h, one slice was mounted on a submerged recording chamber and continuously perfused with aCSF at 30 xC at a rate of 2-3 ml/min.
Electrophysiological recordings
Blind patch-clamp whole-cell recording was performed with 4-8 MV glass microelectrodes filled with internal solution consisting of (mM) : 125 K + gluconate, 5 KCl, 0.5 CaCl 2 , 5 BAPTA, 10 Hepes, 5 MgATP and 0.33 GTP Tris (pH 7.3). In order to elucidate if (+)-5a Compound, similarly to N/OFQ, also induced the NOP receptor-mediated GIRK current, a hyperpolarization voltage ramp protocol was applied. After whole-cell configuration was formed, the potential of the recorded neuron was held at x70 mV, stepped to x60 mV for 100 ms, ramped from x60 mV to x140 mV for 400 ms, and then stepped back to x70 mV ( Fig. 1, inset) . The membrane currents elicited by voltage ramps were acquired through an Axopatch 200B amplifier (Molecular Devices/Axon Instruments, USA) with pClamp 7 software (Molecular Devices/Axon Instruments) and simultaneously recorded with a chart recorder (Gould RS3200) to monitor the time-course of drug effects. The access resistance (10-15 MV) was monitored during the recording period. Only those neurons with unchanged access resistance before and after drug treatments were accepted to ensure that the clamp efficiency had not deteriorated during the recording period.
The effect of the tested NOP receptor agonist was quantified by the percent increment of the membrane current at x140 mV (I x140 ), taking its own I x140 before treatment as 100 %. An I x140 increment >5 % and the induced current having a reversal potential at around x90 mV (the equilibrium potential of K + ions) was considered to be effective. For establishing the concentration-response curve of (+)-5a Compound, the percent increment of I x140 in each neuron was normalized to the maximal effect (E max ) produced by 1 mM N/OFQ, which was 39.4¡4 % increment (n=26) (Chiou et al. 2002) . To quantitatively evaluate the antagonistic effect of various receptor antagonists, their interactions with (+)-5a Compound were examined in the same neuron. Given that not all neurons were sensitive to (+)-5a Compound (see Results section), it was not practical to pre-apply the intended antagonist. Therefore, the tested receptor antagonist was applied to (+)-5a Compound-sensitive neurons after the response of (+)-5a Compound had reached a steady state, which usually took 20-25 min. The response of the tested antagonist was continuously monitored thereafter. In the study verifying whether NOP receptor-mediated GIRK channels were functional in those (+)-5a Compound-unresponsive neurons, N/OFQ was examined after (+)-5a Compound had been applied for at least 20 min. In this set of experiments, Ro 64-6198 was tested in some (+)-5a Compoundunresponsive neurons before N/OFQ was added in order to verify if the neurons unresponsive to (+)-5a Compound were also insensitive to Ro 64-6198.
Immunofluorescence staining
For immunofluorescence studies, 0.2 % Lucifer Yellow was added to the internal solution. After recording, the slice containing the recorded neuron which had been filled with Lucifer Yellow was fixed, re-sectioned and subjected to an immunofluorescent staining of glutamic acid decarboxylase-67 (GAD67), a synthesizing enzyme of GABA (Erlander et al. 1991) . Briefly, after recording, the slices were fixed with 4 % paraformaldehyde at 4 xC for 1 d, and then dehydrated in 30 % sucrose. Dehydrated slices were embedded and re-sectioned in 50-mm sections with a cryostat microtome (Leica CM3050S, Leica Microsystems, Germany). Slice sections were rinsed and washed with phosphate-buffered saline (PBS) three times, followed by 0.3 % Triton X-100 containing PBS (PBST) plus 0.5 % bovine serum albumin (BSA) and then blocked in PBST containing 1 % BSA and 10 % normal goat serum (NGS) for 1 h. Then, slice sections were incubated with the mouse monoclonal antibody against GAD67 (diluted 1 : 1000) (Chemicon, USA) in PBST containing 1 % BSA overnight at 4 xC. Slice sections were then washed with PBST three times, followed by secondary antibody, Alexa 594 (diluted 1 : 100) (Invitrogen, USA) for 1 h. Fluorescent images were acquired with Zeiss LSM 510 Meta confocal microscope (Zeiss, USA) and edited with LSM 510 software (Zeiss).
Morphometric analysis
To compare the morphology of (+)-5a Compoundsensitive and -insensitive neurons, the recorded neurons were reconstructed and analysed. In brief, the recorded neuron was filled with biocytin (1 %), which had been added in the internal solution during recording. After recording, slices were fixed with 4 % paraformaldehyde at 4 xC for 1 d. After several washes with PBS, sections were treated with 1 % H 2 O 2 diluted in PBS for 3 h, then incubated with 1 % Triton X-100 containing PBS plus 10 % NGS and 2 % BSA overnight at room temperature. Biocytin-filled neurons were then revealed using a avidin-biotin-peroxidase complex (ABC) kit (PK-4000, Vector Laboratories, USA), followed by a 3,3k-diaminobenzidine (DAB) kit (SK-4100, Vector Laboratories). The DAB staining was monitored under a microscope (Eclipse TE 2000-U, Japan) and stopped when appropriate by rinsing the sections with PBS. The sections were then mounted with Histokitt mounting medium (Assistent, Germany). The image of the identified neuron was captured under an Olympus BX51 microscope (Olympus, Japan) equipped with a CX9000 CCD camera (MicroBrightField, USA), and reconstructed three-dimensionally using Neurolucida (MicroBrightField). Morphometric analysis of the recorded neurons, including the soma area and dendritic arborization, was performed by Neurolucida Explorer. The dendritic complexity was analysed by Sholl concentric ring analysis.
Chemicals
(+)-5a Compound and Ro 64-6198 were synthesized as reported previously Kolczewski et al. 2003) . UFP-101 was a generous gift from Dr Calò and Dr Guerrini (University of Ferrara, Italy). N/OFQ and AF-DX-116 were purchased from Tocris (UK) and naloxone was purchased from Sigma (USA). All drugs were dissolved in de-ionized water except (+)-5a
Compound and Ro 64-9198, which were dissolved in dimethyl sulfoxide (DMSO). The final concentration of DMSO was kept below 0.1 %, which did not affect the membrane currents elicited by voltage ramps .
Statistics
Data are expressed as the mean¡S.E.M with the number of neurons tested. Usually one neuron was recorded in each slice and 3-4 slices were taken from one rat. Student's t test, one-way ANOVA and x 2 test were used for statistical analysis and a p value <0.05 was considered to be significant.
Results (+)-5a Compound activates GIRK channels in vlPAG neurons
(+)-5a Compound (10 mM) shifted the holding current (I hold in Fig. 1a) outwardly and increased the membrane current elicited by a hyperpolarization ramp command from x60 to x140 mV in vlPAG neurons (Fig. 1 a) . Figure 1b shows the current-voltage (I-V) curves of the membrane currents in a vlPAG neuron before and after treatment with 10 mM (+)-5a Compound, and after washout. The current induced by (+)-5a Compound, obtained by subtracting the current in the control from that in the presence of (+)-5a Compound, displayed inward rectification (Fig. 1 c) . The mean reversal potential of (+)-5a
Compound-elicited current was x90.5¡1.3 mV (n= 49), resembling the equilibrium potential of K + ions estimated by the Nernst equation. Therefore, the K + channel in vlPAG neurons activated by (+)-5a Compound, as by N/OFQ (Chiou et al. 2002) , is the GIRK channel, an inwardly rectifying K + channel that is coupled to G proteins (Ikeda et al. 1997 ).
(+)-5a Compound is less potent and less efficacious than N/OFQ
The effect of (+)-5a Compound on GIRK channels was concentration-dependent (0.1-30 mM). To establish its concentration-response curve (Fig. 2a) , the magnitude of GIRK channel activation induced by (+)-5a Compound was quantified from the percent increment of I x140 obtained in each neuron as described in the Methods section and then, normalized to the maximal increment (39¡4 % increment, n=26) produced by 1 mM N/OFQ (Chiou et al. 2002) , expressed as the percentage of the maximal effect of N/OFQ. (+)-5a Compound, at 10 mM, produced a maximal effect of 47 %, compared to that generated by N/OFQ (Fig. 2 a) .
For comparison, the concentration-response curves of N/OFQ and Ro 64-6198, taken from our previous studies (Chiou et al. 2002 , are also shown in Fig. 2 a. In the present study, 0.3 mM N/OFQ was also tested and produced a similar increment (40.2¡5.4 %, n=32) of I x140 (&, Fig. 2 a) as it did previously (37.2¡ 5.3 %, n=17) (Chiou et al. 2002) . The estimated EC 50 of (+)-5a Compound was 605¡2 nM, which is about 12 times higher than that of N/OFQ, i.e. 52¡6.8 nM (Chiou et al. 2002) . The concentration-response curves of (+)-5a Compound and Ro 64-6198 are similar (Fig. 2 a) with E max values of 46.9¡4.6 % and 61.5¡ 5.6 % , respectively.
(+)-5a Compound activates GIRK channels in about half of the recorded neurons (+)-5a Compound (0.1-30 mM) activated GIRK channels in 49/92 (53 %) recorded neurons and had no effect in the remaining 43 neurons. The responsiveness (>5 % increment of I x140 and the induced current having a reversal potential around x90 mV) of a neuron was independent of its location ; either at the superficial or deeper layer of the slice. The numbers of neurons sensitive to (+)-5a Compound or Ro 64-6198 over the total numbers of tested neurons under various concentrations are depicted in Fig. 2 a. A scatter plot for the responses of all neurons tested with (+)-5a Compound showed that there was a sharp cutoff between (+)-5a Compound-sensitive and -insensitive neurons (Fig. 2b) . Even at the highest tested concentration (30 mM), (+)-5a Compound was still ineffective in some neurons (Fig. 2) , as observed previously with Ro 64-6198 . The effect of (+)-5a Compound was antagonized by NOP, but not opioid or M 2 muscarinic receptor antagonists
In (+)-5a Compound-sensitive neurons, the effect of (+)-5a Compound (0.1-30 mM) in 23/35 (66 %) neurons recorded was antagonized by UFP-101 (Fig. 1 a) , which competitively antagonized the effect of N/OFQ in the same preparation (Chiou et al. 2005) . However, in the remaining 12 neurons, the effects of (+)-5a Compound were not reduced by UFP-101. The effect of (+)-5a Compound was not affected by naloxone, a non-selective m-opioid receptor antagonist. The I x140 increments after treatment with 10 mM (+)-5a Compound in the absence or presence of 1 mM naloxone were not significantly different (119.8¡2.5 % vs. 120.3¡2.4 %, n=3). Previous binding studies (Kolczewski et al. 2003) showed that (+)-5a Compound, at a higher concentration (10 mM), also had affinity at histamine H 3 , muscarinic and s receptors, and sodium channels. It is unlikely that (+)-5a Compound activated GIRK channels through histamine H 3 receptors since there are few histamine H 3 receptors in PAG (Pillot et al. 2002) , and activation of s receptors will block, not activate, K + channels (Zhang & Cuevas, 2005) . Among the five subtypes (M1-M5) of muscarinic receptors, the M2 subtype exists in PAG and activation of M 2 muscarinic receptors also results in GIRK channel activation (Sanada et al. 2007 ). Therefore, we further examined if AF-DX-116, a selective antagonist of M 2 muscarinic receptors, would antagonize the effect of (+)-5a Compound. The result showed that AF-DX-116 did not alter the effect of (+)-5a Compound. After treatment with AF-DX-116 (3 mM), the increase in I x140 by 10 mM (+)-5a Compound was 99.9¡2.5 % (n=6) of that before treatment.
N/OFQ activates GIRK channels via NOP receptors in (+)-5a Compound-insensitive vlPAG neurons
In those (+)-5a Compound-insensitive neurons, we further tested the effect of N/OFQ to verify if their NOP receptors and GIRK channels were functional. In 41/43 neurons which were insensitive to the pretreatment of (+)-5a Compound, N/OFQ (0.3 mM) activated GIRK channels (Fig. 3) in a comparable magnitude as in naive neurons (135.1¡3.2 %, n=41 vs. 137.2¡5.3 %, n=17). The effects of N/OFQ in these neurons were antagonized by UFP-101 (Fig. 3) . This result suggests that (+)-5a Compound is ineffective in a subset of NOP receptors of vlPAG neurons, at which N/OFQ displays similar efficacy as in all neurons. This characteristic of (+)-5a Compound is similar to that of Ro 64-6198 . Therefore, we further investigated the interactions between (+)-5a Compound and Ro 64-6198 in the same neurons. (+)-5a Compound-insensitive neurons are also insensitive to Ro 64-6198, and vice versa
In a neuron that was unaffected by (+)-5a Compound, Ro 64-6198 also failed to induce any membrane current change (Fig. 4 a) . The same result was found in eight other neurons tested. The I x140 values after treatment with 10 mM (+)-5a Compound were 99.7¡0.5 % (n=9) of the controls and were 98.2¡1.0 % (n=9) after further treatment with 10 mM Ro 64-6198. In these neurons, N/OFQ activated GIRK channels in a manner antagonized by UFP-101 (Fig. 4 a-c) . Conversely, in five neurons which were unresponsive to Ro 64-6198, further addition of (+)-5a Compound also had no effect (Fig. 4 d) . The I x140 values after treatment with 10 mM Ro 64-6198 were 100.6¡0.6 % (n=5) of controls, and were 99.6¡0.6 % (n=5) after further treatment with 10 mM (+)-5a Compound. In these neurons, N/OFQ activated GIRK channels (Fig. 4 d) in a manner blocked by UFP-101 (data not shown).
(+)-5a Compound precludes the effect of Ro 64-6198
In (+)-5a Compound-sensitive neurons, which had been treated with the maximal effective concentration of (+)-5a Compound (10 mM), further addition of Ro 64-6198 (10 mM) did not cause any additional change in membrane currents elicited by voltage ramps (Fig. 5 a) in all of the 11 neurons tested. The I x140 values after treatment with 10 mM (+)-5a Compound were 118.8¡3 % of controls (n=11), and were 116.8¡4 % (n=11) after further treatment with 10 mM Ro 64-6198. This result suggests that (+)-5a Compound precluded the effect of Ro 64-6198. 
N/OFQ further enhances GIRK current in (+)-5a
Compound-sensitive neurons
In contrast to Ro 64-6198, N/OFQ (0.3 mM) further enhanced GIRK current in the neurons which were responsive to (+)-5a Compound (Fig. 5 b) . After further treatment with 0.3 mM N/OFQ, the I x140 values in the presence of the maximal effective concentration (10 mM) of (+)-5a Compound increased from 119.6¡ 3.6 % to 132.6¡5.9 % of controls (n=8). The latter response is comparable to that produced by 0.3 mM N/OFQ alone (137.2¡5.3 %, n=17). When N/OFQ was reduced to 50 nM, which is equi-effective to 10 mM of (+)-5a Compound, the increase in I x140 in 10 mM (+)-5a Compound-pretreated neurons was the same as in non-pretreated neurons (129.2¡2.8 %, n=4 vs. 129.6¡3.1 %, n=4). This suggests that even at the maximal effective concentration, (+)-5a Compound did not interact with the equi-effective concentration of N/OFQ.
Most of the (+)-5a Compound-sensitive neurons are GABAergic
To characterize the differences between (+)-5a Compound-sensitive and -insensitive neurons, their electrophysiological properties, morphometric features and neurotransmitter identity were compared. These results are presented in Table 1 and Fig. 6 . As shown on Table 1 , the mean resting membrane potential, input resistance and capacitance of (+)-5a Compound-sensitive (n=78) and -insensitive (n=70) neurons were not significantly different.
Morphometric analysis data showed that (+)-5a
Compound-sensitive (n=8 from six rats) and (+)-5a Compound-insensitive (n=6 from five rats) neurons had comparable soma size and total dendritic length. (+)-5a Compound-sensitive neurons had more primary dendrites (Fig. 6 a) , resembling the triangular Compound-sensitive neurons. Ro 64-6198, 10 mM (a) failed to, but N/OFQ, 0.3 mM (b) did further increase GIRK currents in neurons which were responsive to a pretreatment with (+)-5a Compound at the maximal effective concentration (10 mM). The results were reproduced in another 10 and seven neurons, respectively, under the conditions in panels (a) and (d). Data are mean¡S.E.M. The electrophysiological properties were taken from 70 (+)-5a-insensitive and 78 (+)-5a-sensitive neurons. The recorded neurons either sensitive (n=8 from six rats) or insensitive (n=6 from five rats) to (+)-5a Compound were traced by biocytin-conjugated DAB staining and their 3D morphology was reconstructed by Neurolucida and morphometrically analysed by Neurolucida Explorer. * p<0.05, ** p<0.01, *** p<0.005 vs. the (+)-5a-insensitive group (Student's t test).
and multipolar cells described in the Golgi study (Beitz & Shepard, 1985) . Moreover, compared to (+)-5a Compound-insensitive neurons, the dendrites of (+)-5a Compound-sensitive neurons had more branching nodes leading to greater dendritic orders and more terminal tips. Using Sholl analysis, these two types of neurons could also be differentiated from their dendritic complexity [ Fig. 6a(iii) ]. Neurons sensitive to (+)-5a Compound had more intersections in the Sholl concentric rings particularly in the proximal regions (<100 mm) [ Fig. 6a(iii) ], indicating that these neurons have more complicated dendritic arbors. GABAergic neurons account for 50 % of all the neurons in PAG (Mugnaini & Oertel, 1985) and most of them are interneurons (Reichling & Basbaum, 1990) . We, therefore, examined whether the recorded neurons were GABAergic through a co-localization of GAD67 immmunofluorescent reactivity with Lucifer Yellow, which had been filled in the recorded neuron through the recording electrode after the recording was completed. For those neurons which were sensitive to (+)-5a Compound, 31/40 (78 %) were GABAergic [Fig. 6 b(i) , and the remaining nine (22 %) neurons were non-GABAergic, suggesting a higher proportion (31/40 vs. 9/40, p<0.01, x 2 test) of (+)-5a Compound-sensitive neurons are GABAergic. On the other hand, in 30 (+)-5a Compound-insensitive neurons examined, only 14 (47 %) neurons were GABAergic [ Fig. 6b (ii)] and the remaining 16 (53 %) neurons were non-GABAergic [ Fig. 6b(iii) ].
Discussion
In the present study, we demonstrated that (+)-5a Compound, similarly to N/OFQ (Chiou et al. 2002 , activated GIRK channels in vlPAG neurons (Calò et al. 2000) . The lower efficacy of (+)-5a Compound, compared to N/OFQ, could be because (+)-5a Compound acted as a partial agonist at the same NOP receptors where N/OFQ is a full agonist. However, there was a sharp cut-off in the responses to (+)-5a Compound between (+)-5a Compound-sensitive and -insensitive neurons (Fig. 2 b) . Furthermore, in (+)-5a Compound-insensitive neurons, N/OFQ was as effective as in all other neurons. Hence, it is unlikely that the ineffectiveness of (+)-5a Compound in those insensitive neurons is due to its partial agonist properties in those neurons which had lower density of NOP receptors. Therefore, the lower efficacy of (+)-5a Compound might be explained by the fact that it affected only one subset, whereas N/OFQ affected all of the NOP receptors in vlPAG neurons (see below).
(+)-5a Compound activates GIRK channels through NOP, but not opioid, s, H 3 histamine or M 2 muscarinic receptors Similar to N/OFQ (Chiou et al. 2002 ; Vaughan et al. 1997) and Ro 64-6198 
), (+)-5a
Compound activated GIRK channels in vlPAG neurons. The effects of (+)-5a Compound in most of the tested neurons were mediated through NOP receptors since they were antagonized by UFP-101, which effectively antagonized the effect of N/OFQ in vlPAG neurons (Chiou et al. 2005) . The ineffectiveness of naloxone excludes the involvement of opioid receptors. (+)-5a Compound displayed micromolar affinity at histamine H 3 , muscarinic and s receptors (Kolczewski et al. 2003) . However, these receptors do not appear to be involved in (+)-5a Compoundinduced GIRK activation in vlPAG neurons. First, there are few H 3 receptors in PAG (Pillot et al. 2002) . Second, activation of s receptors does not open GIRK channels (Zhang & Cuevas, 2005) although s receptors do exist in PAG (Mei & Pasternak, 2007) . Third, although M 2 muscarinic receptor activation in PAG induced GIRK currents (Sanada et al. 2007 ), AF-DX-116, a selective M 2 muscarinic receptor antagonist, did not antagonize the effect of (+)-5a Compound. Taken together, it is suggested that the effect of (+)-5a Compound in vlPAG neurons is mediated through NOP, but not opioid, s, H 3 histamine or M 2 muscarinic receptors.
The effect of (+)-5a Compound in a small portion, 18 % (34 % of 53 %), of the recorded neurons was also not antagonized by UFP-101. We did not further investigate these neurons for two reasons. First, it occurred in a limited number (n=12) of recorded neurons. Second, the intracellular dialysis nature of the whole-cell recording technique precluded us from further investigating if Ro 64-6198 also produced a UFP-101-insensitive effect in these neurons since these neurons have been treated with two drugs, (+)-5a Compound and UFP-101.
(+)-5a Compound activates a subset of NOP receptors in vlPAG neurons
Unlike N/OFQ which activated GIRK channels through NOP receptors in almost all (96 %) of the recorded neurons (Chiou et al. 2002) , (+)-5a Compound activated GIRK channels in only 53 % of the recorded neurons. Among these neurons, 66 % were sensitive to UFP-101, suggesting that the effects of (+)-5a Compound in 35 % (66 % of 53 %) of vlPAG neurons are mediated through NOP receptors. However, in those (+)-5a Compound-insensitive neurons, NOP receptors are functional since N/OFQ still activated GIRK channels through NOP receptors. It is, therefore, suggested that (+)-5a Compound, similarly to Ro 64-6198 , affected just one subset, not all, of the NOP receptors in vlPAG neurons.
(+)-5a Compound and Ro 64-6198 activate the same subset of NOP receptors in vlPAG neurons Several findings from our study suggest that (+)-5a Compound and Ro 64-6198 activate the same subset of NOP receptors in vlPAG neurons. First, a similar ratio (35 %) of the recorded neurons were sensitive to (+)-5a Compound and Ro 64-6198 . Second, (+)-5a Compound-insensitive neurons were also unresponsive to Ro 64-6198, and vice versa, whereas N/OFQ activated GIRK channels in these neurons. Third, (+)-5a Compound, at the maximal effective concentration precluded the effect of Ro 64-6198.
A majority of the (+)-5a Compound-sensitive neurons are GABAergic
Morphological studies demonstrated that bipolar, triangular and multipolar neurons are present in PAG (Beitz & Shepard, 1985) . (+)-5a Compound-sensitive neurons have 3-6 primary dendrites resembling the triangular and multipolar neurons. Interestingly, the ratio (53 %) of (+)-5a Compound-sensitive neurons in PAG, in the present electrophysiological study is very close to the ratio (52 %) of triangular plus multipolar neurons in the previous Golgi study (Beitz & Shepard, 1985) . The triangular and multipolar neurons have more primary dendrites and complicated dendritic arbors implying that (+)-5a Compound-sensitive neurons may receive and integrate various excitatory/ inhibitory/regulatory inputs. Furthermore, our posthoc GAD67 immunostaining verified that 78 % of the (+)-5a Compound-sensitive neurons are GABAergic. Since GABAergic neurons account for 50 % of all the neurons in PAG (Mugnaini & Oertel, 1985) and most of them are interneurons (Reichling & Basbaum, 1990) , our findings suggest that (+)-5a Compound-sensitive neurons play an important role in GABA-mediated pain regulation. Activation of GIRK channels on GABAergic interneurons results in excitation of the vlPAG, leading to anti-nociception through activation of the descending pain inhibitory pathway. It remains to be elucidated if Ro 64-6198 or (+)-5a Compound, when injected into the vlPAG, will produce antinociception through this disinhibition mechanism.
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